Clinical Trial: Role of UC-MSC and CM to Inhibit Vision Loss in Retinitis Pigmentosa Phase II/III
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Retinitis Pigmentosa
Study Type: INTERVENTIONAL
Official Title: Role of Umbilical Cord-derived Stem Cell Transplantation and Conditioned Medium to Inhibit Vision Loss in Retinitis Pigmentosa Phase II/III
Brief Summary:
The study will perform UC-MSCs and CM transplantation.There are two groups with different dosages.The first group will be transplanted with 1.5 million cells, meanwhile, the second group is 5 million cells.Each group consists of 15 subjects.All groups will be transplanted via the peribulbar route.All groups will be observed until six months.
Read more